Clinical Trials on Lipoprotein Metabolism Disorder in Australia

Total 4793 results

Syneos Health
SynerK Pharmatech (Suzhou) Limited

Recruiting

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Elevated Low-Density Lipoprotein Cholesterol

Australia
Eli Lilly and Company

Completed

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events (KRAKEN)

Lipoprotein Disorder

Australia, China, Hungary, Brazil, Japan, Germany, Netherlands, United States
The University of Western Australia
National Heart Foundation, Australia

Completed

Regulation of Lipoprotein Transport in Metabolic Syndrome

Obesity | Cardiovascular Disease | Lipid Disorders

Australia
Silence Therapeutics plc

Active, not recruiting

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

Cardiovascular Diseases | Atherosclerosis | Lipoprotein(a)

Australia, Czechia, Denmark, Netherlands, Slovakia, South Africa, United Kingdom
AstraZeneca

Completed

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

Metabolic Syndrome | Dyslipidemia

Australia
University of Adelaide

Completed

Effects of Periodic Fasting Versus Daily Energy Restriction on Metabolic Health (PREFER)

Insulin Resistance

Australia
The University of Western Australia

Completed

Regulation of Lipoprotein Metabolism in Obese Men

Obesity | Insulin Resistance | Dyslipidemia

Australia
HighTide Biopharma Pty Ltd

Completed

A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia

Hypercholesterolemia

Australia
Swisse Wellness Pty Ltd
Commonwealth Scientific & Industrial Research Organisation; BIONAP SRL

Completed

Investigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)

Hypercholesterolemia

Australia
University of Adelaide
Royal Adelaide Hospital; University of South Australia

Terminated

Can Brief High-intensity Interval Training Mitigate the Adverse Consequences of High-fat Overfeeding? (GAINHIT)

Insulin Resistance

Australia
The University of Western Australia

Completed

Effect of Abdominal Obesity on Lipoprotein Metabolism

Obesity | Insulin Resistance | Dyslipidemia

Australia
Barmherzige Brüder Linz

Completed

Possible Links Between Inflammation and Lipid Metabolism

Sepsis | Inflammation | Lipid Metabolism Disorder | LPS

Austria
AstraZeneca

Completed

Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

Metabolic Syndrome | Dyslipidemia

Australia
Chong Kun Dang Pharmaceutical

Completed

To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors

Dyslipidemias

Australia
Louise Farrer

Withdrawn

Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial (ShareIT)

Depression

Australia
Novartis Pharmaceuticals

Completed

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Cardiovascular Disease and Lipoprotein(a)

China, Germany, United States, Colombia, South Africa, Italy, Spain, Belgium, Egypt, Hungary, Taiwan, Turkey, Japan, Netherlands, Australia, Austria, Canada, Czechia, France, Israel, Switzerland, United Kingdom, Korea, Republic of, Th... and more
University of South Australia
American Egg Board

Completed

Independent Effects of High-cholesterol (High-egg) and High-saturated Fat Diets on LDL-cholesterol

Hypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical Inactivity

Australia
Australian National University
University of Sydney; Commonwealth Scientific and Industrial Research Organisation... and other collaborators

Completed

Beyond Ageing Project: A Study for the Prevention of Depression

Depressive Disorder | Depression

Australia
Mondelēz International, Inc.
University of Sydney

Completed

Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content and GI Consumed Alone.

Metabolism and Nutrition Disorders

Australia
Amgen

Completed

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody (FLOREY)

Primary Hyperlipidemia and Mixed Dyslipidemia

Australia
University of Adelaide

Completed

Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (IMPART)

Diabetes | Metabolic Syndrome

Australia
The University of Western Australia
National Health and Medical Research Council, Australia

Unknown

Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils (FIFH)

Familial Hypercholesterolaemia | Hypertriglyceridaemia

Australia
University of Adelaide

Completed

Intermittent Fasting for Metabolic Health, Does Meal Timing Matter?

Insulin Resistance | Type 2 Diabetes

Australia
Marea Therapeutics

Recruiting

Study of MAR001 in Adults With Metabolic Dysfunction

Hypertriglyceridemia

Australia
The University of Western Australia

Unknown

High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome

Metabolic Syndrome X

Australia
University of Adelaide

Completed

Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session. (HOTAIR2)

Obesity | Type 2 Diabetes

Australia
Western Sydney Local Health District

Completed

Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome (MVENT)

Metabolic Syndrome | Hypercholesterolemia

Australia
University of Adelaide

Completed

Hyperbaric Oxygen Treatment Ameliorates Insulin Resistance (HOTAIR)

Obesity | Type 2 Diabetes

Australia
LipimetiX Development, LLC

Completed

Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia

Hypercholesterolemia | Hyperlipoproteinemia Type II

Australia
Menzies Institute for Medical Research
Deakin University

Active, not recruiting

Microvascular Insulin Resistance and Mixed Meal Challenge

Insulin Resistance

Australia
University of Adelaide
Salk Institute for Biological Studies

Terminated

Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? (RESHAPE2)

Insulin Resistance | Type2 Diabetes

Australia
Bond Biosciences

Terminated

A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers

Hereditary Hemochromatosis

Australia
Novo Nordisk A/S

Completed

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany, Australia
Evopoint Biosciences Inc.

Completed

The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 in Health Subject

Gout

Australia
University of Adelaide

Completed

Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)

Individuals at Risk of Developing Diabetes

Australia
University of Adelaide
Australasian Hyperbaric & Diving Medicine Research Trust

Completed

Does Hyperbaric Oxygen Therapy Lead to a Sustained Increase in Insulin Sensitivity? (HOTAIR3)

Overweight and Obesity | Insulin Sensitivity

Australia
Garvan Institute of Medical Research

Completed

Effects of Excess Energy Intake on Metabolic Risk (EXCESS)

Insulin Resistance

Australia
The George Institute
Pfizer; Royal Prince Alfred Hospital, Sydney, Australia; Lipid and Cardiovascular... and other collaborators

Completed

Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health

Hypercholesterolemia

Australia
Zosano Pharma Corporation

Completed

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

Hypoglycemia

Australia
Bristol-Myers Squibb

Completed

Safety Study of BMS-816336 in Healthy Male Subjects

Dyslipidemia | Diabetes Mellitus, Non-Insulin-Dependent

Australia
Royal Perth Hospital

Recruiting

Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans (EMPA-SNS)

Obesity | Type 2 Diabetes Mellitus | Metabolic Syndrome

Australia
Baker Heart Research Institute
National Heart Foundation, Australia

Unknown

Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity

Metabolic Syndrome

Australia
Monash University
National Heart Foundation, Australia

Withdrawn

Renal Denervation in Diabetes.

Diabetes

Australia
The University of Western Australia
King Edward Memorial Hospital

Completed

The Cycle Study: a Study of the Effectiveness of Cycling Exercise in Breaking the Cycle of Pregnancy Diabetes

Gestational Diabetes Mellitus

Australia
Baker Heart Research Institute

Unknown

Cortisol and Nutritional Sympathetic Responsiveness

Obesity | Metabolic Syndrome | Insulin Resistance

Australia
Resverlogix Corp
South Australian Health and Medical Research Institute

Terminated

Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

Coronary Artery Disease | Dyslipidemia

Australia
Olive Lifesciences Pvt Ltd
College of Health and Biomedicine, Victoria University

Unknown

The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome

Obesity | Metabolic Syndrome

Australia
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals Australia Pty Ltd

Completed

Phase 2 Study of NGM282 in Patients With Type 2 Diabetes

Diabetes Mellitus

Australia, New Zealand
University of Adelaide
Salk Institute for Biological Studies; University of South Australia

Completed

Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID) (TRIFFID)

Obesity | Type2 Diabetes

Australia
Sanofi

Terminated

Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care (RELIANCE)

Diabetes Mellitus, Type 2

Australia

Clinical Trials on Lipoprotein Metabolism Disorder in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations